leadership
confidence high
sentiment neutral
materiality 0.50
Impact Biomedical enters three-year CEO employment agreement with Frank Heuszel
IMPACT BIOMEDICAL INC.
- Term from Oct 3, 2024 to Oct 3, 2027; base salary $200K year 1, $250K years 2 and 3.
- Mandatory bonus: $150K year 1, $100K each year 2 and 3; discretionary bonuses eligible.
- Option grant of 300,000 shares at $3.00/share under 2023 Equity Incentive Plan.
- Agreement defines termination for cause and good reason; executive remains CEO, Chairman, President.